Yan Wan-Li, Gong Shu-Rong, Yu Rong-Guo, Chen Han
Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Key Laboratory of Critical Care Medicine, Fujian Provincial Hospital, The Third Department of Critical Care Medicine, Fujian Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Key Laboratory of Critical Care Medicine, Fujian Provincial Hospital, Cardiovascular Intensive Care Unit, Fujian Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.
Ann Med. 2025 Dec;57(1):2523555. doi: 10.1080/07853890.2025.2523555. Epub 2025 Jun 25.
It is unclear whether different modes of continuous renal replacement therapy (CRRT) impact post-filter ionized calcium concentrations during regional citrate anticoagulation (RCA) when using calcium-containing replacement fluid.
This prospective, single-center, observational cohort study will screen all patients receiving CRRT for eligibility. General clinical information will be collected before commencing CRRT treatment. Patients will be randomly assigned to either the continuous veno-venous hemofiltration (CVVH) or continuous veno-venous hemodialysis (CVVHD) group and switch to the alternative mode in the subsequent treatment session. Pre-filter and post-filter ionized calcium, systemic total and ionized calcium, and effluent total calcium will be measured 2 h after the initiation of CRRT. Electrolyte levels, arterial blood gases, hourly citrate dose, and total citrate dose will be recorded every 6 h until the end of CRRT. The primary outcome is the difference in ionized calcium concentrations at each site over time between the two modes.
This study will build upon clinical practice to explore the differential effects of various CRRT modes on ionized and total calcium in patients undergoing RCA-CRRT with calcium-containing replacement solutions.
在使用含钙置换液进行局部枸橼酸抗凝(RCA)时,不同模式的连续性肾脏替代治疗(CRRT)是否会影响滤器后离子钙浓度尚不清楚。
这项前瞻性、单中心观察性队列研究将筛选所有接受CRRT的患者是否符合入选标准。在开始CRRT治疗前收集一般临床信息。患者将被随机分配至连续性静脉-静脉血液滤过(CVVH)组或连续性静脉-静脉血液透析(CVVHD)组,并在随后的治疗阶段转换为另一种模式。在CRRT开始2小时后测量滤器前和滤器后离子钙、全身总钙和离子钙以及滤出液总钙。每6小时记录一次电解质水平、动脉血气、每小时枸橼酸剂量和总枸橼酸剂量,直至CRRT结束。主要结局是两种模式下各部位离子钙浓度随时间的差异。
本研究将基于临床实践,探讨不同CRRT模式对接受含氯化钙置换液的RCA-CRRT患者离子钙和总钙水平的差异影响。